FIELD: medicine; veterinary.
SUBSTANCE: invention can be used for simulation of non-alcoholic steatohepatitis. For this purpose, laboratory rats are used. Method involves introducing with animal fodder of 90 days 5 g of melted beef fat. Starting from day 60 of simulation, additionally performing intramuscular injections of tetracycline in dosage of 100 mg/kg once a day for 10 days.
EFFECT: method provides development of resistant morphofunctional changes, typical for non-alcoholic steatohepatitis, with reduced length of simulation.
1 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF MODELING NON-ALCOHOLIC STEATOHEPATITIS IN RATS | 2009 |
|
RU2394281C1 |
| METHOD FOR MODELING FATTY LIVER DISEASE OF MIXED GENESIS IN RATS | 2020 |
|
RU2757199C1 |
| METHOD OF SIMULATING NON-ALCOHOLIC FATTY LIVER DISEASE IN RATS | 2015 |
|
RU2600476C1 |
| METHOD FOR STEP-BY-STEP MODELING OF NONALCOHOLIC FATTY PANCREATIC DISEASE IN RATS | 2021 |
|
RU2770555C1 |
| METHOD OF SIMULATING MULTIPLE ORGAN PATHOLOGY IN RATS | 2011 |
|
RU2453002C1 |
| ANTYSTEATOSIS AGENT | 2019 |
|
RU2702003C1 |
| METHOD FOR MODELLING NON-ALCOHOLIC FATTY LIVER DISEASE BY DIET RICH IN FRUCTOSE | 2019 |
|
RU2728418C1 |
| NALMEFEN, NALTREXONE OR DERIVATIVES THEREOF FOR USE IN TREATING (NON)-ALCOHOLIC STEATOHEPATITIS OR NON-ALCOHOLIC FATTY LIVER DISEASE | 2017 |
|
RU2717677C1 |
| USING LACTITOL AND AN ORAL DOSAGE FORM FOR TREATING AND PREVENTING NON-ALCOHOLIC FATTY LIVER DISEASE | 2018 |
|
RU2692243C1 |
| METHOD FOR SIMULATING DIET-INDUCED METABOLIC SYNDROME | 2020 |
|
RU2740007C1 |
